The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBUY.L Regulatory News (CBUY)

  • There is currently no data for CBUY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

23 Sep 2008 07:00

RNS Number : 0330E
@UK PLC
23 September 2008
 



Under embargo until 7:00am

23 September 2007

@UK PLC

("@UK" or the "Company")

Unaudited Interim Results for the six months ended 30 June 2008

@UK PLC (AIM:ATUK.L), a provider of software solutions that facilitate eCommerce and eProcurement in the government, health and private sectors, today announces its unaudited interim results for the six months ended 30 June 2008.

OPERATING AND FINANCIAL REVIEW 

Financial results 

Revenue for the six months to 30 June 2008 decreased 7% to £1,078,000 (2007: £1,165,000), reflecting a slow down in the market for new company formations in the second quarter

The operating loss was £706,000 (2007: £1,521,000). After net interest income of £32,000 (2007: £90,000), the loss before tax was £674,000, compared to £1,431,000 in 2007. During the six months our cash reduced by £602,000 to £1,189,000 (2007reduction of £1,237,000). The loss before tax and cash outflow in the first half were both substantially reduced from the levels in the second half of 2007by 28% and 45% respectively, as the benefits of cost reductions flowed through.  

Operating Review 

We have made progress in some areas in the half year. Costs have been reduced; full supplier engagement commenced on our contract with NHS Supply Chain, and work started on the first full implementation of our wider marketplace offering for the Health Sector.

Throughout the year we have been developing a new "spend analysis" product to analyse the procurement data of public sector organisations. This builds on the existing expertise of @UK and Coding International in this area. The product is now at pilot stage with a large collaborative procurement organisation within the NHS.

Since the half year we have received the first marketplace order from an NHS Trust providing acute hospital services and our marketplace has been chosen by a major English university. This will be our first major client in that sector. These projects are expected to be completed by the year end.

The major issue continues to be the time taken to convert prospects to sales. The level of interest from both NHS suppliers and trusts is good, but conversion is taking longer than foreseen. This is unlikely to change in the second half.

Company Formations

Revenues in our Company Formation services business fell by 12% compared to the same period last year. This ended a number of years continuous growth in this business and reflected a fall in the number of companies incorporated in England & Wales in the first half of around 34%. We have made some changes to our marketing and since 30 June sales have recovered to nearer 2007 levels.

Outlook and current trading

Activity in our markets is likely to remain slow for the rest of the year, with the work on generating new business unlikely to show through in sales until the start of 2009.

John Aiken

Chief Executive 

23 September 2008

CONSOLIDATED INCOME STATEMENT (UNAUDITED)

Notes

months to

30 June

2008

£'000

months to

30 June

2007

£'000

Year ended

31 Dec

2007

£'000

Revenue

2

1,078

1,165

2,330

Cost of sales

(307)

(414)

(851)

Gross profit

771

751

1,479

Administrative expenses

(1,396)

(2,254)

(3,889)

Share based payments

(14)

(18)

(26)

Operating loss before exceptional item

(639)

(1,521)

(2,436)

Exceptional reorganisation costs

3

(67)

-

(84)

Operating loss

(706)

(1,521)

(2,520)

Finance income

34

93

160

Finance cost

(2)

(3)

(7)

Loss before taxation

(674)

(1,431)

(2,367)

Taxation

-

-

-

Loss for the year attributable to equity shareholders of the parent

(674)

(1,431)

(2,367)

Loss per share - basic and diluted

4

1.8

3.8p 

6.3p 

Revenue and operating loss all derive from continuing operations.

 

 

CONSOLIDATED BALANCE SHEET (UNAUDITED)

30 June

2008

£'000

30 June

2007

£'000

31 Dec

2007

£'000

Assets

Non-current assets

Goodwill

96

96

96

Other intangible assets

32

58

47

Property, plant and equipment

374

589

502

502

743

645

Current assets

Trade and other receivables

330

336

312

Cash and cash equivalents

1,189

2,882

1,791

1,519

3,218

2,103

Total assets

2,021

3,961

2,748

Liabilities

Current liabilities

Trade and other payables

(526)

(866)

(586)

Income tax

(3)

(3)

(3)

Financial liabilities - borrowings

(12)

(12)

(12)

(541)

(881)

(601)

Non-current liabilities

Financial liabilities - borrowings

(48)

(60)

(55)

(48)

(60)

(55)

Total liabilities

(589)

(941)

(656)

Net assets

1,432

3,020

2,092

Shareholders' equity

Called up share capital

378

378

378

Share premium

10,114

10,114

10,114

Other reserve

630

630

630

Share based payment reserve

91

69

77

Accumulated losses

(9,781)

(8,171)

(9,107)

Total equity attributable to equity shareholders of the parent

1,432

3,020

2,092

   CONSOLIDATED CASH FLOW STATEMENT (UNAUDITED)

months to

30 June

2008

£'000

months to

30 June

2007

£'000 

Year ended

31 Dec

2007

£'000 

Cash flows from operating activities

Loss for the period

(674)

(1,431)

(2,367)

Adjustments for:

Interest

(32)

(90)

(153)

Depreciation of property, plant & equipment

132

129

262

Amortisation of other intangible assets

15

14

28

Share based payments

14

18

26

Changes in working capital

Trade and other receivables

(18)

61

86

Trade and other payables

(60)

15

(264)

Net cash used by operations

(623)

(1,284)

(2,382)

Tax paid

-

-

-

Net cash outflow from operating activities

(623)

(1,284)

(2,382)

Cash flows from investing activities

Interest received

34

93

160

Interest paid

(2)

(3)

(7)

Purchase of intangible assets

-

(11)

(15)

Purchase of property, plant and equipment

(4)

(25)

(72)

Net cash inflow from investing activities

28

54

66

Cash flows from financing activities

Repayments of borrowings

(7)

(7)

(12)

Net cash outflow from financing

(7)

(7)

(12)

Net decrease in cash and cash equivalents

(602)

(1,237)

(2,328)

Cash and cash equivalents at beginning of period

1,791

4,119

4,119

Cash and cash equivalents at end of period

1,189

2,882

1,791

  CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED)

Share capital 

£'000

Share premium 

£'000

Other reserve 

 £'000

Share based payment 

reserve

£'000

Accumul-ated losses 

£'000

Total

 

£'000

Balance as at 1 January 2007

376

10,114

607

51

(6,740)

4,408

Loss for the period

-

-

-

-

(1,431)

(1,431)

Share based payments

-

-

-

18

-

18

Shares issued in the period

2

-

23

-

-

25

Balance as at 30 June 2007

378

10,114

630

69

(8,171)

3,020

Loss for the period

-

-

-

-

(936)

(936)

Share based payments

-

-

-

8

-

8

Balance as at 31 December 2007

378

10,114

630

77

(9,107)

2,092

Loss for the period

-

-

-

-

(674)

(674)

Share based payments

-

-

-

14

-

14

Shares issued in the period

-

-

-

-

-

-

Balance as at 30 June 2008

378

10,114

630

91

(9,781)

1,432

  NOTES TO THE FINANCIAL STATEMENTS

 

1. Basis of preparation

These interim financial statements have been prepared in accordance with the accounting policies set out in the 

Annual Report and Accounts for the year ended 31 December 2007 and the interpretation of those

accounting standards underlying the accounting policies. IAS 34, Interim Financial Reporting, has not been

applied. The interim financial statements have been issued in accordance with the AIM Rules of the London Stock

Exchange and are unaudited. The financial information set out does not constitute statutory accounts for the

purposes of section 240 of the Companies Act 1985. The auditors' report on the statutory accounts for the year

ended 31 December 2007 which have been filed with the Registrar of Companies was unqualified and does not

contain a statement under Companies Act 1985 sections 237(2) or (3).

 

The preparation of financial statements requires estimates and assumptions that affect the reported amounts of

assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses

during the reporting period. Although the estimates are based on management's best knowledge of the amounts,

events or actions, actual results may differ from those estimates.

 

Copies of the interim statements for the six months ended 30 June 2008 are being sent to all shareholders and

to the AIM Team. Details can also be found on the company's website at www.ukplc.net. Further copies of the

interim statements and copies of the accounts for the year ended 31 December 2007 can be obtained by writing

to the Company Secretary, @UK PLC, 5 Jupiter House, Calleva Park, Aldermaston, Berkshire RG7 8NN.

 

This announcement was approved by the board of @UK PLC on 22 September 2008.

2. Revenue (unaudited)

Set out below is an analysis of revenue recognised between principal product categories, which the Directors use to assess

future revenue flows from customers.

Revenue 

months to

30 June

2008

£'000

months to

30 June

2007

£'000

Year ended

31 Dec

2007

£'000

Company formation services

627

709

1,305

Web and ecommerce services

451

456

1,025

1,078

1,165

2,330

3.  Exceptional reorganisation costs

Reorganisation costs represent the costs incurred in reducing staff numbers.

4.  Loss per share (unaudited)

The calculations for loss per share are based on the weighted average number of shares in issue during the period

37,779,822 (6 months to 30 June 2007: 37,665,515; year ended 31 December 2007: 37,723,138) and the following losses:

months to

30 June 2008

£'000

months to

30 June 2007

£'000

Year ended

31 Dec 2007

£'000

Unadjusted earnings:

Loss on ordinary activities after tax

674)

(1,431)

(2,367)

Add back:

Exceptional reorganisation costs

67

-

84

Share based payments

14

18

26

Adjusted earnings:

(593)

(1,413)

(2,257)

 

The share options and warrants are not dilutive as they would not increase the loss per share in the year.

 

The basic and diluted loss per share calculated on the adjusted earnings is 1.6p (6 months to 30 June

20073.8p; year ended 31 December 2007: 6.0p).

5.  Post Balance Sheet Events

There are no post balance sheet events requiring disclosure.

For further information please contact:

@UK PLC

John Aiken, CEO

+44 (0) 118 963 7000

Beaumont Cornish Limited 

Roland Cornish

+44 (0) 20 7628 3396

  

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR FKBKPOBKDQCB
Date   Source Headline
5th Feb 20204:41 pmRNSSecond Price Monitoring Extn
5th Feb 20204:35 pmRNSPrice Monitoring Extension
31st Jan 20205:30 pmRNSCloudbuy
27th Jan 20202:09 pmRNSResult of General Meeting
24th Jan 20204:34 pmRNSHolding(s) in Company
24th Jan 20204:32 pmRNSHolding(s) in Company
10th Jan 20205:47 pmRNSDirector dealing
9th Jan 20209:12 amRNSProposed cancellation of AIM admission
7th Jan 20205:31 pmRNSFourth Interest Payment for New CLS
4th Nov 20192:00 pmRNSSeventh Interest Payment
28th Aug 20194:40 pmRNSHolding(s) in Company
21st Aug 20197:00 amRNSInterim Results
15th Jul 201910:36 amRNSHolding(s) in Company
11th Jul 20197:00 amRNSThird Interest Payment for New CLS
26th Apr 20197:00 amRNSSixth Interest Payment
16th Apr 20192:34 pmRNSResult of AGM
16th Apr 20197:00 amRNSAGM Statement
8th Apr 20197:00 amRNSDirector/PDMR Shareholding
28th Mar 20197:00 amRNSSale of Company Formations Business
26th Mar 20195:07 pmRNSHolding(s) in Company
20th Mar 20199:36 amRNSCorrection: Final Results
20th Mar 20197:00 amRNSFinal Results, Funding Update & Directorate Change
20th Feb 20198:06 amRNSHolding(s) in Company
8th Feb 20197:00 amRNSTrading Statement
5th Feb 20195:22 pmRNSHolding(s) in Company
4th Jan 20193:07 pmRNSSecond Interest Payment for New CLS
29th Oct 20184:40 pmRNSSecond Price Monitoring Extn
29th Oct 20184:35 pmRNSPrice Monitoring Extension
29th Oct 20187:00 amRNSFifth Interest Payment
24th Oct 201810:45 amRNSHolding(s) in Company
22nd Aug 20187:13 amRNSInterim Results
19th Jul 20187:00 amRNSFirst Interest Payment for New CLS
28th Jun 20187:00 amRNSDirector Dealing of Shares
30th May 20187:00 amRNSFourth Interest Payment
18th Apr 201811:08 amRNSResult of AGM
17th Apr 20187:00 amRNSAGM Statement
11th Apr 20187:00 amRNSTR-1: Notification of Major Interest in Shares
16th Mar 20187:10 amRNSFinal Results and Date of AGM
2nd Feb 20187:24 amRNSTR-1: Notification of Major Interest in Shares
24th Jan 20187:00 amRNSTrading Update
19th Jan 20185:20 pmRNSTR-1: Notification of Major Interest in Shares
27th Dec 20172:10 pmRNSResult of General Meeting
8th Dec 20177:00 amRNSIssue of up to £3.4m Convertible Loan Notes
30th Oct 20175:14 pmRNSTR-1: Notification of Major Interest in Shares
30th Oct 20175:08 pmRNSTR-1: Notification of Major Interest in Shares
30th Oct 20175:04 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
30th Oct 20177:00 amRNSThird Interest Payment
20th Sep 20177:00 amRNSDirector/PDMR Shareholding
16th Aug 201712:12 pmRNSInterim Results - Replacement
16th Aug 20177:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.